Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
SPRINGHOUSE, PA (December 3, 2009): A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage.
Dec 2, 2009